Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Sichuan Huiyu Pharmaceutical Co's OCF Margin % or its related term are showing as below:
SHSE:688553'
s OCF Margin % Range Over the Past 10 Years
Min: -94.14 Med: 22.2 Max: 237.59
Current: 19.06
During the past 9 years, the highest OCF Margin % of Sichuan Huiyu Pharmaceutical Co was 237.59%. The lowest was -94.14%. And the median was 22.20%.
SHSE:688553's OCF Margin % is ranked better than 75.96% of 965
companies
in the Drug Manufacturers industry
Industry Median: 10.1
vs SHSE:688553: 19.06
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sichuan Huiyu Pharmaceutical Co OCF Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Sichuan Huiyu Pharmaceutical Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sichuan Huiyu Pharmaceutical Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sichuan Huiyu Pharmaceutical Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Sichuan Huiyu Pharmaceutical Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sichuan Huiyu Pharmaceutical Co (SHSE:688553) has a OCF Margin % of 25.24% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sichuan Huiyu Pharmaceutical Co and its competitors. This is 14% above median its historical median of 22.20. According to the industry distribution chart, Sichuan Huiyu Pharmaceutical Co ranks #232 out of 965 companies in the Drug Manufacturers industry, placing it in the top 24%.
Is Sichuan Huiyu Pharmaceutical Co's OCF Margin % too high?
Sichuan Huiyu Pharmaceutical Co's current OCF Margin % of 25.24% is 14% above median its 10-year median of 22.20. The Drug Manufacturers industry median OCF Margin % is 10.10. Sichuan Huiyu Pharmaceutical Co's value of 25.24% is 149.9% above this industry median. Based on the distribution chart, Sichuan Huiyu Pharmaceutical Co ranks #232 out of 965 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sichuan Huiyu Pharmaceutical Co has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sichuan Huiyu Pharmaceutical Co's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sichuan Huiyu Pharmaceutical Co ranks #232 out of 965 companies for OCF Margin %. This places Sichuan Huiyu Pharmaceutical Co in the top 24% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 10.10. Sichuan Huiyu Pharmaceutical Co's value of 25.24% is 149.9% above this benchmark. While the company's 10-year median is 22.20 vs. the industry median of 10.10, Sichuan Huiyu Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.10, based on 965 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sichuan Huiyu Pharmaceutical Co's current OCF Margin % of 25.24% is 149.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sichuan Huiyu Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sichuan Huiyu Pharmaceutical Co's current OCF Margin % is 25.24%, which is 14% above median its own 10-year median of 22.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sichuan Huiyu Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Sichuan Huiyu Pharmaceutical Co (SHSE:688553) is currently considered Fairly Valued. The stock's GF Value™ is ¥10.81, compared to a current price of ¥10.77 — trading 0.4% below its estimated fair value. The current OCF Margin % is 25.24%, which is 14% above median its 10-year median of 22.20 and 149.9% above the Drug Manufacturers industry median of 10.10. Sichuan Huiyu Pharmaceutical Co's overall GF Score™ is 70/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Sichuan Huiyu Pharmaceutical Co (SHSE:688553), the current OCF Margin % is 25.24% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sichuan Huiyu Pharmaceutical Co (SHSE:688553) Overvalued in 2026?
Based on GuruFocus' analysis, Sichuan Huiyu Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥10.77 is trading 0.4% below its estimated GF Value™ of ¥10.81.
GuruFocus considers Sichuan Huiyu Pharmaceutical Co to be Fairly Valued.
Key valuation signals for SHSE:688553:
OCF Margin %: 25.24% (14% above median its 10-year median of 22.20)
GF Value™: ¥10.81 vs. price of ¥10.77 (0.4% below fair value)
Industry Position: 149.9% above the Drug Manufacturers median (#232 of 965)
No single metric tells the full story. See the SHSE:688553 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688553 has been successfully added to your 
